25th Nov 2021 15:17
Equinox International Holdings PLC - UK-based medical cannabis supplier - Intends to list on the AIM market of the London Stock Exchange, with finnCap acting as global coordinator and joint bookrunner alongside States Bridge Capital.
Date of admission, as well as funds to be raised and how many shares have not been finalised, however proceeds from the IPO will go towards building a cultivation, extraction and production facility for medical cannabis in the UK.
Equinox holds a schedule one controlled drugs licence from the Home Officer for production and supplying medical cannabis on a 20-acre site.
"The UK medical cannabis market is forecast to be one of the largest in Europe and Equinox has a significant first-mover advantage to build a British champion and transform patients' lives. Our wholesale distribution strategy and land-to-brand focus will enable us to become a leading, vertically integrated medical cannabis company providing consistent, high-quality products," said Chief Executive Officer Xan Morgan.
"We have one of the first commercially scaled medical cannabis cultivation and production licences issued by the UK Home Office. With our leadership team's experience in project delivery, operational management, strategic governance and business development, we're well positioned to maximise this exciting opportunity," Morgan added.
By Dayo Laniyan; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.